m6A-dependent glycolysis enhances colorectal cancer progression

Chaoqin Shen(Sun Yat-sen University), Jie Hong(Shanghai Jiao Tong University), Pingping Xu(Shanghai Innovative Research Center of Traditional Chinese Medicine), Yingying Cao(Nanjing Agricultural University), Tingting Yan(Nanjing Drum Tower Hospital), Dan Ma(Aston University), Yanru Ma(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Institute of Hematology), Xianglong Tian(Shanghai Eighth People Hospital), Xinyu Zhang(University of California, Santa Barbara), Youwei Zhang(Shanghai University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Haoyan Chen(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University)
Molecular Cancer
April 3, 2020
10.1186/s12943-020-01190-w
Cited by 465

Related Papers

Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
Roles of Chk1 in cell biology and cancer therapy
|International Journal of Cancer|2013|456
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
<i>F. nucleatum</i> targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer
|Gut|2020|303
Enterotoxigenic Bacteroides fragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p
|Gastroenterology|2021|291